HLS Therapeutics (HLS Therapeutics) Other Operating Expense : $37.51 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Other Operating Expense?

HLS Therapeutics's Other Operating Expense for the three months ended in Dec. 2023 was $8.43 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $37.51 Mil.

HLS Therapeutics's quarterly Other Operating Expense increased from Jun. 2023 ($9.80 Mil) to Sep. 2023 ($9.88 Mil) but then declined from Sep. 2023 ($9.88 Mil) to Dec. 2023 ($8.43 Mil).

HLS Therapeutics's annual Other Operating Expense increased from Dec. 2021 ($35.94 Mil) to Dec. 2022 ($40.13 Mil) but then declined from Dec. 2022 ($40.13 Mil) to Dec. 2023 ($37.51 Mil).

HLS Therapeutics Other Operating Expense Historical Data

The historical data trend for HLS Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Other Operating Expense Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

37.80

38.65

35.94

40.13

37.51

HLS Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															10.30	9.40	9.80	9.88	8.43

HLS Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $37.51 Mil.

HLS Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics (HLS Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

HLS:Canada

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

HLS Therapeutics (HLS Therapeutics) Headlines

From GuruFocus

Automodular Corp. (TSX:AM) - Strong Buy

By Elliot Luchansky, CFA Elliot Luchansky, CFA • 03-21-2013